Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 9;6(1):ytab532.
doi: 10.1093/ehjcr/ytab532. eCollection 2022 Jan.

MitraClip implantation in non-obstructive hypertrophic cardiomyopathy: the ever-expanding landscape of transcatheter edge-to-edge repair

Claudio Montalto  1   2 , Panagiotis Xaplanteris  3
Affiliations
Editorial

MitraClip implantation in non-obstructive hypertrophic cardiomyopathy: the ever-expanding landscape of transcatheter edge-to-edge repair

Claudio Montalto et al. Eur Heart J Case Rep. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
The landscape of transcatheter edge-to-edge repair: current indications, available evidence, and ESC recommendations. The class of recommendation and level of evidence for transcatheter edge-to-edge repair in various subsets of patients with mitral valve regurgitation are shown. The most recent 2021 ESC/EACTS guidelines for the management of valvular heart disease were considered. EACTS, European Association for CardioThoracic Surgery; ESC, European Society of Cardiology; H(n)OCM, Hypertrophic (non) obstructive cardiomyopathy; HTx, heart transplantation; LVAD, left ventricular assist device; MR, mitral regurgitation.
None
See this image and copyright information in PMC

Comment in

  • doi: 10.1093/ehjcr/ytab446

References

    1. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS. et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395–1406. - PubMed
    1. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM. et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018;379:2307–2318. - PubMed
    1. Sorajja P, Pedersen WA, Bae R, Lesser JR, Jay D, Lin D. et al. First experience with percutaneous mitral valve plication as primary therapy for symptomatic obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2016;67:2811–2818. - PubMed
    1. Lucarelli K, Troisi F, Scarcia M, Grimaldi M.. Transcatheter mitral valve repair for the treatment of severe mitral regurgitation and exertional pre-syncope in a patient with non-obstructive hypertrophic cardiomyopathy: a case report. Eur Heart J - Case Rep 2021;ytab446. doi:10.1093/ehjcr/ytab446. - DOI - PMC - PubMed
    1. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT. et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006;114:2232–2239. - PubMed

Publication types

LinkOut - more resources